scorecardresearch
Friday, May 3, 2024
TopicBharat Biotech

Topic: Bharat Biotech

After Congress’ Jairam & Tharoor, now Milind Deora questions ‘speedy’ approval for Covaxin

Milind Deora joins Shashi Tharoor and Jairam Ramesh in questioning ‘premature approval’ for Bharat Biotech’s Covaxin even though the Congress has officially welcomed the vaccine.

Those doubting Bharat Biotech’s efficacy mentally challenged, says Union minister Pradhan

Dharmendra Pradhan's remarks came after Congress leaders raised doubts on the approval of Bharat Biotech's vaccine, for restricted use, while its 3rd phase trial is still underway.

Thank you, Akhilesh Yadav. BJP can take its vaccine nationalism from here

Samajwadi Party chief Akhilesh Yadav erred big time with his ‘BJP’s vaccine’ comment. But it highlights how BJP is winning the battle of public perception in Covid management.

Submit Covaxin safety reports every 15 days, include mild side-effects — govt to Bharat Biotech

Drug regulator DCGI’s approval to Bharat Biotech’s Covaxin for emergency use is subject to certain conditions detailed in the ‘permission form’.

Congress questions why Bharat Biotech’s Covaxin was cleared without completing phase-3 trials

Congress’ Anand Sharma, head of parliamentary panel, says health ministry needs to explain sidestepping protocol because Covaxin will be given to frontline workers.

Covaxin approved as it’s more likely to act against mutant Covid strain, says ICMR chief

In an interview, ICMR chief Balram Bhargava addressed questions that have been raised about the approval granted to Covaxin in the absence of efficacy data.

Covaxin & Covishield get govt nod for emergency use, stage set for Covid immunisation to begin

Drugs Controller General of India has granted 'conditional approval' to the vaccine candidates. A third candidate by Cadila Healthcare has got nod to conduct Phase III clinical trial.

Bharat Biotech’s Covaxin given conditional nod based on incomplete Phase 3 trial results data

Covaxin has been recommended for restricted emergency use authorisation by a subject expert committee appointed by the Central Drugs Standard Control Organisation.

Everything you need to know about Covaxin, India’s controversial Covid vaccine candidate

Bharat Biotech's Covaxin has been recommended for restricted emergency use authorisation by an expert committee appointed by the Central Drugs Standard Control Organisation.

Expert panel of India’s drug regulator recommends approval for Bharat Biotech’s Covaxin

The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation on Saturday deliberated on the emergency use authorisation application of Bharat Biotech.

On Camera

Two documents, Modi-Macron visits—India-France defence partnership is touching new heights

Horizon 2047 signed during Modi's visit to France in July 2023 and the defence industrial roadmap during Macron’s visit to India in January 2024 guide the strategic bonhomie between the two countries.

How govt brought Vodafone Idea back from the brink & earned a neat profit in the process

In 2021, the government allowed telcos to convert interest on deferred spectrum payments and AGR dues into equity. This made it the single largest stakeholder in Vodafone Idea.

China builds road through Shaksgam Valley, India registers protest

New Delhi has, in past, too, objected to Chinese construction activities in Shaksgam Valley. Work in this strategic region gathered pace after the 2017 Doklam stand-off.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.